Search

Breast cancer is one of the most prevalent cancers among women worldwide, and early detection of the disease can be lifesaving. Detecting breast cancer early allows for treatment to begin faster, increasing the chances of a successful outcome. Machine learning helps in the early detection of breast cancer even in places where there is no access to a specialist doctor. The rapid advancement of machine learning, and particularly deep learning, leads to an increase in the medical imaging community's interest in applying these techniques to improve the accuracy of cancer screening. Most of the data related to diseases is scarce. On the other hand, deep-learning models need much data to learn well. For this reason, the existing deep-learning models on medical images cannot work as well as other images. To overcome this limitation and improve breast cancer classification detection, inspired by two state-of-the-art deep networks, GoogLeNet and residual block, and developing several new features, this paper proposes a new deep model to classify breast cancer. Utilizing adopted granular computing, shortcut connection, two learnable activation functions instead of traditional activation functions, and an attention mechanism is expected to improve the accuracy of diagnosis and consequently decrease the load on doctors. Granular computing can improve diagnosis accuracy by capturing more detailed and fine-grained information about cancer images. The proposed model's superiority is demonstrated by comparing it to several state-of-the-art deep models and existing works using two case studies. The proposed model achieved an accuracy of 93% and 95% on ultrasound images and breast histopathology images, respectively. [ABSTRACT FROM AUTHOR]

Brain tumors (BTs) are deadly diseases that can strike people of every age, all over the world. Every year, thousands of people die of brain tumors. Brain-related diagnoses require caution, and even the smallest error in diagnosis can have negative repercussions. Medical errors in brain tumor diagnosis are common and frequently result in higher patient mortality rates. Magnetic resonance imaging (MRI) is widely used for tumor evaluation and detection. However, MRI generates large amounts of data, making manual segmentation difficult and laborious work, limiting the use of accurate measurements in clinical practice. As a result, automated and dependable segmentation methods are required. Automatic segmentation and early detection of brain tumors are difficult tasks in computer vision due to their high spatial and structural variability. Therefore, early diagnosis or detection and treatment are critical. Various traditional Machine learning (ML) techniques have been used to detect various types of brain tumors. The main issue with these models is that the features were manually extracted. To address the aforementioned insightful issues, this paper presents a hybrid deep transfer learning (GN-AlexNet) model of BT tri-classification (pituitary, meningioma, and glioma). The proposed model combines GoogleNet architecture with the AlexNet model by removing the five layers of GoogleNet and adding ten layers of the AlexNet model, which extracts features and classifies them automatically. On the same CE-MRI dataset, the proposed model was compared to transfer learning techniques (VGG-16, AlexNet, SqeezNet, ResNet, and MobileNet-V2) and ML/DL. The proposed model outperformed the current methods in terms of accuracy and sensitivity (accuracy of 99.51% and sensitivity of 98.90%). [ABSTRACT FROM AUTHOR]

Due to the high mortality of many cancers and their related diseases, the prediction and prognosis techniques of cancers are being extensively studied to assist doctors in making diagnoses. Many machine-learning-based cancer predictors have been put forward, but many of them have failed to become widely utilised due to some crucial problems. For example, most methods require too much training data, which is not always applicable to institutes, and the complicated genetic mutual effects of cancers are generally ignored in many proposed methods. Moreover, a majority of these assist models are actually not safe to use, as they are generally built on black-box machine learners that lack references from related field knowledge. We observe that few machine-learning-based cancer predictors are capable of employing prior knowledge (PrK) to mitigate these issues. Therefore, in this paper, we propose a generalisable informed machine learning architecture named the Informed Attentive Predictor (IAP) to make PrK available to the predictor's decision-making phases and apply it to the field of cancer prediction. Specifically, we make several implementations of the IAP and evaluate its performance on six TCGA datasets to demonstrate the effectiveness of our architecture as an assist system framework for actual clinical usage. The experimental results show a noticeable improvement in IAP models on accuracies, f1-scores and recall rates compared to their non-IAP counterparts (i.e., basic predictors). [ABSTRACT FROM AUTHOR]